Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medtronic PLC MDT

Healthcare Medical Devices
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic... see more

Recent & Breaking News (NYSE:MDT)

Perfect Trade Setups, How to Play WHR, SYY, MDT and EXC

Marketwired March 12, 2013

With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis

Thomson Reuters ONE March 11, 2013

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity(TM) Renal Denervation System

Thomson Reuters ONE March 10, 2013

Medtronic Submits IDE to FDA for U.S. Randomized Clinical Trial for Uncontrolled Hypertension Patients with Systolic Blood Pressure Between 140-160 mm Hg

Thomson Reuters ONE March 7, 2013

Leveraging Results to Drive New Innovation - Research Report on Medtronic, Inc., Edwards Lifesciences, Cyberonics, Inc., HeartWare International and Luxottica Group SpA

PR Newswire March 7, 2013

Symplicity(TM) Renal Denervation System One of First Devices Accepted to Participate in Concurrent Review for Joint FDA Premarket Approval and Medicare National Coverage Determination

Thomson Reuters ONE March 6, 2013

Medtronic Announces CE Mark and European Launch of Attain Performa® Portfolio of Quadripolar Leads

Thomson Reuters ONE March 5, 2013

Medtronic Seeking Long-Distance Runners Who Benefit from Medical Technology

Thomson Reuters ONE March 4, 2013

Medtronic Approved to Update Resolute Integrity Stent's 'CE' Mark Labeling on Dual Antiplatelet Therapy

Thomson Reuters ONE March 4, 2013

Abbott Laboratories, Boston Scientific, Medtronic and MAKO Surgical Under StockCall's Microscope

PR Newswire March 4, 2013

Medtronic EVP & President Chris O'Connell to Speak at Cowen Healthcare Conference

Thomson Reuters ONE February 28, 2013

Medtronic Announces CE Mark for Engager(TM) Transcatheter Valve

Thomson Reuters ONE February 28, 2013

Meta-Analysis Demonstrates Efficacy of Pillar Procedure for the Treatment of Snoring and Mild to Moderate Obstructive Sleep Apnea

Thomson Reuters ONE February 27, 2013

Medtronic Gains First FDA Approval to Conduct Early Feasibility Medical Device Study

Thomson Reuters ONE February 26, 2013

Medtronic CFO Gary Ellis to Speak at Citi Global Healthcare Conference

Thomson Reuters ONE February 25, 2013

Early Hours Recap on EXC, WCRX, MDT and DNDN

Marketwired February 25, 2013

FDA Approves Longer Lengths of Medtronic's Resolute Integrity Stent

Thomson Reuters ONE February 25, 2013

Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.

PR Newswire February 21, 2013

New Research Shows Significant Benefits of Medtronic Deep Brain Stimulation Earlier in Progression of Parkinson's Disease

Marketwired February 14, 2013

High Profile HealthCare Companies: Leading Pharma Company Secures New Patents

PR Newswire February 14, 2013